IGBA’s establishes CEO Advisory Committee
15 February 2022 | News
The committee has 13 leading multinational companies from Canada, Europe, India, Israel, Japan and the US
Image credit: www.igbamedicines.org
The International Generic and Biosimilar medicines Association (IGBA) has established a CEO Advisory Committee composed of 13 leading multinational companies from Canada, Europe, India, Israel, Japan, and the US.
The committee members are:
- Chirag Patel, President and Co-CEO, Amneal Pharmaceuticals
- Jeff Watson, President and CEO, Apotex
- Pankaj Patel, Chairman - Cadila Healthcare
- Samina Hamied, Executive Vice-Chairperson - Cipla
- Satish Reddy, Chairman - Dr Reddy's Laboratories
- Lucas Sigman, CEO, Insud Pharma SL
- Vinita Gupta, CEO, Lupin
- Richard Saynor, CEO, Sandoz
- Peter Goldschmidt, CEO and Chairman Executive Board - STADA Arzneimittel
- Dilip Shanghvi, Managing Director - Sun Pharmaceutical Industries
- Kåre Schultz, President and CEO, Teva Pharmaceuticals Industries
- David Peix, CEO, Towa Pharma International Holdings
- Michael Goettler, CEO, Viatris
